...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Wonder if Don will

KK2 - I think it is safe to say that the authors do not have all of the information in the epigenetics zone as RVX-208 now has some 40 articles written about it and yet no mention whatsoever. Zenith Epigenetics Ltd with 11 ongoing trials and again no mention. Given this information deficit I wonder how many more companies, drugs and trials are out there in the epigenetics space that they have missed.

Good find on the article KK2.

tada

Share
New Message
Please login to post a reply